法国体外诊断市场 - 增长、趋势、COVID-19 影响和预测(2022 - 2027 年)

市场按测试类型、产品、可用性、应用(传染病、糖尿病、癌症/肿瘤学、心脏病学和其他应用)和最终用户细分

市场快照

France In Vitro Diagnostics Market Overview
Study Period: 2018 - 2026
Base Year: 2021
CAGR: 7.5 %
France In Vitro Diagnostics Market Major Players

Need a report that reflects how COVID-19 has impacted this market and its growth?

市场概况

体外诊断试验是用于对来自人体的标本进行体外检查以提供筛查、诊断或治疗监测目的信息的试验。慢性病患病率的上升一直是该市场增长的主要驱动力。这种不断上升的流行率增加了对早期有效诊断测试的需求。慢性病患病率的上升也增加了床旁 (POC) 诊断的使用。此外,对个性化医疗和伴随诊断的认识和接受度的提高也有助于市场增长。

Scope of the report

As per the scope of this report, in vitro diagnostics involves medical devices and consumables that are utilized to perform in vitro tests on various biological samples. They are used for the diagnosis of various medical conditions, such as Diabetes and Cancer.

By Test Type
Clinical Chemistry
Molecular Diagnostics
Immuno Diagnostics
Other Techniques
By Product
Instrument
Reagent
Other Product
By Usability
Disposable IVD Devices
Reusable IVD Devices
By Application
Infectious Disease
Diabetes
Cancer/Oncology
Cardiology
Other Applications
By End-users
Diagnostic Laboratories
Hospitals and Clinics
Other End-users

Report scope can be customized per your requirements. Click here.

主要市场趋势

预计在癌症中的应用将占据很大的市场份额

癌症生物标志物表明体内存在癌症。生物标志物可以是由肿瘤分泌的分子或身体对癌症存在的特定反应。遗传、表观遗传、蛋白质组学、糖组学和成像生物标志物可用于癌症诊断、预后和流行病学。使用体外诊断测试在非侵入性收集的生物流体(如血液或血清)中分析此类生物标志物。

根据法国国家癌症研究所的数据,报告的癌症病例在男性和女性中都急剧增加。根据该研究所 2019 年的一份报告,在过去 30 年中,报告的癌症病例数量在男性中增加了 65%,在女性中增加了 95%。因此,随着未来癌症发病率进一步上升,早期诊断的体外诊断需求也有望上升。

France In Vitro Diagnostics Market Trends

France In Vitro Diagnostics Market Overview

竞争格局

法国是一个发达地区,拥有完善的医疗体系。结果,该国出现了体外诊断市场的许多参与者。此外,一些国内玩家也一直在法国市场展开竞争。这些因素使该地区非常具有竞争力。

Table of Contents

  1. 1. INTRODUCTION

    1. 1.1 Study Deliverables

    2. 1.2 Study Assumptions

    3. 1.3 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Rising Prevalence of Chronic Diseases

      2. 4.2.2 Increasing Awareness and Acceptance of Personalized Medicine and Companion Diagnostics

      3. 4.2.3 Increasing Use of Point-of-care (POC) Diagnostics

    3. 4.3 Market Restraints

      1. 4.3.1 Stringent Regulations

    4. 4.4 Porter's Five Force Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION

    1. 5.1 By Test Type

      1. 5.1.1 Clinical Chemistry

      2. 5.1.2 Molecular Diagnostics

      3. 5.1.3 Immuno Diagnostics

      4. 5.1.4 Other Techniques

    2. 5.2 By Product

      1. 5.2.1 Instrument

      2. 5.2.2 Reagent

      3. 5.2.3 Other Product

    3. 5.3 By Usability

      1. 5.3.1 Disposable IVD Devices

      2. 5.3.2 Reusable IVD Devices

    4. 5.4 By Application

      1. 5.4.1 Infectious Disease

      2. 5.4.2 Diabetes

      3. 5.4.3 Cancer/Oncology

      4. 5.4.4 Cardiology

      5. 5.4.5 Other Applications

    5. 5.5 By End-users

      1. 5.5.1 Diagnostic Laboratories

      2. 5.5.2 Hospitals and Clinics

      3. 5.5.3 Other End-users

  6. 6. COMPETITIVE LANDSCAPE

    1. 6.1 Company Profiles

      1. 6.1.1 Abbott Laboratories

      2. 6.1.2 Becton, Dickinson and Company

      3. 6.1.3 BioMerieux

      4. 6.1.4 Bio-Rad Laboratories, Inc.

      5. 6.1.5 Danaher Corporation

      6. 6.1.6 F. Hoffmann-La Roche AG

      7. 6.1.7 QIAGEN N.V.

      8. 6.1.8 Siemens Healthcare GmbH

      9. 6.1.9 Sysmex Corporation

      10. 6.1.10 Thermo Fischer Scientific Inc.

    2. *List Not Exhaustive
  7. 7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Competitive Landscape covers- Business Overview, Financials, Products and Strategies and Recent Developments

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The France In-Vitro Diagnostics Market market is studied from 2018 - 2026.

The France In-Vitro Diagnostics Market is growing at a CAGR of 7.5% over the next 5 years.

Thermo Fischer Scientific Inc, QIAGEN N.V., Abbott Laboratories, Siemens Healthcare GmbH, F. Hoffmann-La Roche AG are the major companies operating in France In-Vitro Diagnostics Market.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!